D. Gerdes, Edith Olah Jorunn Eyford

G. Centers?dept, Hanne Meijers-Heijboer; Dept. of Clinical Genetics, Nijmegen Medical Center Nicoline Hoogerbrugge; Family Cancer Clinic, The Netherlands Cancer Institute, Amsterdam: Senno Verhoef; The Netherlands Foundation for the detection of hereditary tumours, Margreet Ausems; Dept. of Clinical Genetics and Human Genetics

A. Regional and G. Service, Joan Paterson; Medical Genetics Services for Wales, Cardiff: Jonothan Gray; St James's Hospital, Dublin and National Centre for Medical Genetics, South East of Scotland Regional Genetics Service Peninsula Clinical Genetics, vol.20

E. Service, J. Brewer, and . Rankin, Victoria Murday; South East Thames Regional Genetics Service, Guys Hospital London: Louise Izatt, Gabriella Pichert; North West Thames Regional Genetics Service, Harrow: HuwDorkins; Leicestershire Clinical Genetics Service, Yorkshire Regional Genetics Service

G. Manchester-regional, . Service, . Manchester:-gareth, F. Evans, A. Lalloo et al., Anne Robinson; Nottingham Centre for Medical Genetics Susan Ritchie; Northern Clinical Genetics Service Sarah Durell; Department of Cancer Genetics, Royal Marsden Hospital: Ros Eeles, John Burn; Oxford Regional Genetics Service North Trent Clinical Genetics Service Wessex Clinical Genetics Service

V. Roussy, Agnès Chompret

. Centre-léon and . Bérard, Valérie Bonadona; Centre François Baclesse, Caen: Pascaline Berthet

. Papin, Alain Lortholary

A. Lortholary-;-centre-antoine-lacassagne, Marc Frénay; Hôpital D'Enfants CHU, Dijon: Laurence Faivre, Institut Bergonié, p.21

C. Dugast-;-polyclinique and . Courlancy, Liliane Demange; Hôpital de la Timone, Marseille: Hélène Zattara-Cannoni

C. Villeneuve, Montpellier: Mehrdad Noruzinia; CHRU Dupuytren

J. Ferlay, F. Bray, P. Pisani, D. Parkin, and . Globocan, Cancer Incidence, Mortality and Prevalence Worldwide, Version 1.0, 2000.

D. Easton, How many more breast cancer predisposition genes are there?, Breast Cancer Research, vol.22, issue.1, pp.14-21, 1999.
DOI : 10.1038/10290
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC138504

B. Ponder, Cancer genetics, Nature, vol.411, issue.6835, pp.336-377, 2001.
DOI : 10.1038/35077207

A. Antoniou, P. Pharoah, S. Narod, H. Risch, J. Eyfjord et al., Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies, The American Journal of Human Genetics, vol.72, issue.5, pp.1117-1147, 2003.
DOI : 10.1086/375033

D. Easton, D. Ford, and D. Bishop, Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium, Am J Hum Genet, vol.56, pp.265-71, 1995.

D. Ford, D. Easton, M. Stratton, S. Narod, D. Goldgar et al., Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families, The American Journal of Human Genetics, vol.62, issue.3, pp.676-89, 1998.
DOI : 10.1086/301749

C. Begg, On the Use of Familial Aggregation in Population-Based Case Probands for Calculating Penetrance, CancerSpectrum Knowledge Environment, vol.94, issue.16, pp.1221-1227, 2002.
DOI : 10.1093/jnci/94.16.1221

A. Venkitaraman, Cancer Susceptibility and the Functions of BRCA1 and BRCA2, Cell, vol.108, issue.2, pp.171-82, 2002.
DOI : 10.1016/S0092-8674(02)00615-3

M. Razandi, A. Pedram, E. Rosen, and E. Levin, BRCA1 Inhibits Membrane Estrogen and Growth Factor Receptor Signaling to Cell Proliferation in Breast Cancer, Molecular and Cellular Biology, vol.24, issue.13, pp.5900-5913, 2004.
DOI : 10.1128/MCB.24.13.5900-5913.2004

M. Thompson, R. Jensen, P. Obermiller, D. Page, and J. Holt, Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression, Nature Genetics, vol.8, issue.4
DOI : 10.1016/0304-3835(80)90042-7